Autori: Broderick TL, Jankowski M, Wang D, Danalache BA, Parrott CR, Gutkowska J.

Editorial: ISRN Endocrinol., 2012:736860., 2012.

Rezumat:

Reduced expression of GATA4, a transcriptional factor for structural and cardioprotective genes, has been proposed as a factor contributing to the development of cardiomyopathy. We investigated whether the reduction of cardiac GATA4 expression reported in diabetes alters the expression of downstream genes, namely, atrial natriuretic peptide (ANP), B-type natriuretic, peptide (BNP), and α- and β-myosin heavy chain (MHC). db/db mice, a model of type 2 diabetes, with lean littermates serving as controls, were studied. db/db mice exhibited obesity, hyperglycemia, and reduced protein expression of cardiac GLUT4 and IRAP (insulin-regulated aminopeptidase), the structural protein cosecreted with GLUT4. Hearts from db/db mice had reduced protein expression of GATA4 (~35%) with accompanying reductions in mRNA expression of ANP (~40%), BNP (~85%), and α-MHC mRNA (~50%) whereas expression of β-MHC mRNA was increased by ~60%. Low GATA4 was not explained by an increased ligase or atrogin1 expression. CHIP protein content was modestly downregulated (27%) in db/db mice whereas mRNA and protein expression of the CHIP cochaperone HSP70 was significantly decreased in db/db hearts. Our results indicate that low GATA4 in db/db mouse heart is accompanied by reduced expression of GATA4-regulated cardioprotective and structural genes, which may explain the development of cardiomyopathy in diabetes.

PMID: 22474596 [PubMed – in process] PMCID: PMC3313578

Cuvinte cheie: GATA4,ANP, BNP, cardioprotection, db/db mice, model of type 2 diabetes // GATA4,ANP, BNP, cardioprotection, db/db mice, model of type 2 diabetes

URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313578/?tool=pubmed